Kronos Bio, Inc. Revenue
Kronos Bio, Inc. reported Revenue of $1.86 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2025-05-08
- Kronos Bio, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-03-31 was $1.86M, a 26.03% decline year-over-year.
- Kronos Bio, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2024-12-31 was $2.27M, a 0.70% decline year-over-year.
- Kronos Bio, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2024-09-30 was $2.37M, a 158.45% increase year-over-year.
- Kronos Bio, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2024-06-30 was $2.69M, a 44.21% increase year-over-year.
- Kronos Bio, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $9.85M, a 56.62% increase from fiscal 2023.
- Kronos Bio, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $6.29M.
- Kronos Bio, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $0.00.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2025-03-31 | $1.86M 10-Q · filed 2025-05-08 | $4.13M derived: sum of 2 quarters · filed 2025-05-08 | $6.50M derived: sum of 3 quarters · filed 2025-05-08 | $9.19M derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | $2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $4.64M derived: sum of 2 quarters · filed 2025-03-18 | $7.33M derived: sum of 3 quarters · filed 2025-03-18 | $9.85M 10-K · filed 2025-03-18 |
| 2024-09-30 | $2.37M 10-Q · filed 2024-11-13 | $5.06M derived: sum of 2 quarters · filed 2024-11-13 | $7.58M 10-Q · filed 2024-11-13 | $9.86M derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-06-30 | $2.69M 10-Q · filed 2024-08-08 | $5.21M 10-Q · filed 2024-08-08 | $7.49M derived: sum of 3 quarters · filed 2025-05-08 | $8.41M derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-03-31 | $2.52M 10-Q · filed 2025-05-08 | $4.81M derived: sum of 2 quarters · filed 2025-05-08 | $5.72M derived: sum of 3 quarters · filed 2025-05-08 | $7.59M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $3.20M derived: sum of 2 quarters · filed 2025-03-18 | $5.07M derived: sum of 3 quarters · filed 2025-03-18 | $6.29M 10-K · filed 2025-03-18 |
| 2023-09-30 | $917.00K 10-Q · filed 2024-11-13 | $2.78M derived: sum of 2 quarters · filed 2024-11-13 | $4.00M 10-Q · filed 2024-11-13 | $4.00M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $1.86M 10-Q · filed 2024-08-08 | $3.08M 10-Q · filed 2024-08-08 | $3.08M derived: sum of 3 quarters · filed 2024-08-08 | $3.08M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.22M 10-Q · filed 2024-05-09 | $1.22M derived: sum of 2 quarters · filed 2024-05-09 | $1.22M derived: sum of 3 quarters · filed 2024-05-09 | $1.22M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $0.00 derived: sum of 2 quarters · filed 2024-03-21 | $0.00 derived: sum of 3 quarters · filed 2024-03-21 | $0.00 10-K · filed 2024-03-21 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-10 |